Larson Financial Group’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
S
Larson Financial Group's NVAX Position: Q2 2026 in Review
Larson Financial Group increased its Novavax (NVAX) stake by 69% in Q2 2026, buying an estimated $1.21K and bringing the position to 330 shares worth $3.11K. The position accounts for ﹤0.01% of the portfolio, ranked #2963.
Larson Financial Group first reported a position in NVAX in Q1 2020 and has held it in 24 quarters since. The position peaked at $165K in Q2 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Larson Financial Group held 330 shares of Novavax worth $3.11K as of Q2 2026.
- Larson Financial Group bought 135 Novavax shares in Q2 2026, an estimated $1.21K.
- Novavax made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2963 holding.
- Larson Financial Group first reported a position in Novavax in Q1 2020 and has held it in 24 quarters since.
- Larson Financial Group's Novavax position peaked at $165K in Q2 2021.
- 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.